The introduction of Retatrutide in the UK is generating significant excitement within the weight management community. This innovative dual compound – targeting both GLP-1 and GIP – promises a significantly new solution to addressing obesity . Currently , options have been restricted for many, and Retatrutide represents a encouraging opportunit